Position in JNJ
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$3,238,371
+$253,026 QoQ
Shares Held
12,751
+4.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
#1,950
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 75%
Shared 0%
None 25%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026180 WEALTH ADVISORS, LLC holds $30,472,982 across 12 Drug Manufacturers - General names. JNJ ranks #4 (10.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
44,833 | $5,761,040 | |
| 2 | AMGN |
Amgen Inc
|
15,157 | $5,488,652 | |
| 3 | AZN |
Astrazeneca PLC
|
20,498 | $3,886,830 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
12,751 | $3,238,371 | |
| 5 | OGN |
Organon & Co.
|
226,383 | $3,065,225 | |
| 6 | LLY |
ELI LILLY & Co
|
2,524 | $3,027,361 | |
| 7 | ABBV |
AbbVie Inc.
|
6,433 | $1,618,800 | |
| 8 | PFE |
Pfizer Inc
|
47,953 | $1,154,708 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,238,371 | 12,751 | Shares | Sole | 2026-07-07 | |
| 2026-03-31 | $2,985,345 | 12,213 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $2,682,278 | 12,961 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $2,509,845 | 13,536 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $2,065,180 | 13,520 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $2,367,200 | 14,274 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $2,066,909 | 14,292 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $2,161,718 | 13,339 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $1,937,789 | 13,258 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $2,073,554 | 13,108 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $2,064,422 | 13,171 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $2,127,389 | 13,659 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $2,278,051 | 13,763 | Shares | Sole | 2023-07-12 | |
| 2023-03-31 | $2,445,280 | 15,776 | Shares | Sole | 2023-04-07 | |
| 2022-12-31 | $2,673,597 | 15,135 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $2,642,184 | 16,174 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $2,867,319 | 16,153 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $2,887,785 | 16,294 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $2,741,909 | 16,028 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $2,800,571 | 17,341 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $2,804,863 | 17,026 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,856,238 | 17,379 | Shares | Sole | 2021-05-25 | |
| 2020-12-31 | $2,878,008 | 18,287 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $2,691,303 | 18,077 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $2,533,871 | 18,018 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $2,082,213 | 15,879 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||